ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Geriatric Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,129Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 27

$1.11M Total Retail Price of All Prescriptions

Rank: 1 out of 27

716 Patients Receiving at Least One Drug in Part D
15% Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Pennsylvania
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

9% of this provider’s 716 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs*

13% of this provider’s prescriptions were for brand-name drugs, compared to an average of 15%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
RISPERIDONE 1,054 209 140 A 1 2
CLONAZEPAM 1,001 72 172 B 2 1
TRAZODONE HCL 759 78 151 3 4
LORAZEPAM 728 177 134 B 4 5
BENZTROPINE MESYLATE 676 105 125 R 5 9
SERTRALINE HCL 646 91 113 6 10
CITALOPRAM HBR 627 62 96 7 6
MIRTAZAPINE 597 177 99 8 7
QUETIAPINE FUMARATE 560 21 72 A 9 3
ZOLPIDEM TARTRATE 521 31 88 10 22
BUPROPION HCL SR 515 22 93 11 18
VENLAFAXINE HCL ER 509 39 75 12 8
ALPRAZOLAM 473 39 63 B 13 13
BUSPIRONE HCL 435 53 82 14 20
LAMOTRIGINE 419 80 65 15 15
ABILIFY 415 27 61 A 16 12
GABAPENTIN 374 42 61 17 23
FLUOXETINE HCL 354 74 47 18 19
DIVALPROEX SODIUM ER 352 52 51 19 17
LITHIUM CARBONATE 344 <11 57 20 21
CHLORPROMAZINE HCL 340 25 68 A 21 28
PAROXETINE HCL 287 39 43 22 26
HYDROXYZINE PAMOATE 265 15 69 R 23 31
METHYLPHENIDATE HCL 260 15 41 S2 24 33
TOPIRAMATE 253 0 36 25 35
HALOPERIDOL 230 19 30 A 26 32
BUPROPION HCL 200 46 41 27 37
AMITRIPTYLINE HCL 190 52 38 R 28 38
TEMAZEPAM 182 24 30 B 29 36
OLANZAPINE 174 <11 19 A 30 11
CYMBALTA 173 <11 29 31 25
ZIPRASIDONE HCL 169 0 22 A 32 27
CLOZAPINE 152 50 11 A 33 16
SEROQUEL XR 150 12 16 A 34 30
ESCITALOPRAM OXALATE 130 37 20 35 14
PROPRANOLOL HCL 121 11 21 36 45
CLOMIPRAMINE HCL 121 17 11 R 36 45
OXCARBAZEPINE 112 0 17 38 39
DIAZEPAM 97 30 13 B 39 40
FLUPHENAZINE HCL 94 11 12 A 40 48
PRAZOSIN HCL 93 24 28 41 49
CLONIDINE HCL 91 0 17 42 50
HYDROXYZINE HCL 89 12 28 R 43 51
THIORIDAZINE HCL 82 <11 <11 A R 44 52
LEVOTHYROXINE SODIUM 82 11 14 44 52
THIOTHIXENE 79 <11 <11 A 46 55
DOXEPIN HCL 75 11 19 47 43
FLUVOXAMINE MALEATE 72 13 14 48 56
AMPHETAMINE SALT COMBO 70 0 15 S2 49 57
BUPROPION XL 61 <11 14 50 29
CARBAMAZEPINE 59 0 13 51 62
RISPERDAL CONSTA 55 <11 <11 A 52 44
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.